Literature DB >> 12420112

Medical, nutritional and technological properties of lactulose. An update.

Christian Schumann1.   

Abstract

The undigestable disaccharide lactulose has been in medical use for over 40 years, mainly in the treatment of portosystemic encephalopathy and of constipation. Pharmacodynamics of lactulose make it an efficacious and safe drug in these indications. But the reason for its numerous potential benefits are under research now. The major principle of action is the promotion of growth and activity of lactic acid bacteria in the gut which counteract detrimental species such as clostridia or salmonellae. This shows that prebiotic action, if used accordingly, can have medically significant effects. The mechanism of action, medical and prebiotic effects, veterinary uses, and technological properties of lactulose, e. g. in yoghurt production are reviewed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12420112     DOI: 10.1007/s00394-002-1103-6

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  17 in total

Review 1.  Infant food applications of complex carbohydrates: Structure, synthesis, and function.

Authors:  Dorothy L Ackerman; Kelly M Craft; Steven D Townsend
Journal:  Carbohydr Res       Date:  2016-11-11       Impact factor: 2.104

2.  Lactulose and Lactobacillus plantarum, a potential complementary synbiotic to control postweaning colibacillosis in piglets.

Authors:  A A Guerra-Ordaz; G González-Ortiz; R M La Ragione; M J Woodward; J W Collins; J F Pérez; S M Martín-Orúe
Journal:  Appl Environ Microbiol       Date:  2014-06-06       Impact factor: 4.792

3.  Fructose malabsorption may be gender dependent and fails to show compensation by colonic adaptation.

Authors:  Andrew Szilagyi; Paula Malolepszy; Samara Yesovitch; Christina Vinokuroff; Usha Nathwani; Albert Cohen; Xiaoqing Xue
Journal:  Dig Dis Sci       Date:  2007-03-15       Impact factor: 3.199

Review 4.  The Bridge Between Ischemic Stroke and Gut Microbes: Short-Chain Fatty Acids.

Authors:  Zongwei Fang; Mingrong Chen; Jiafen Qian; Chunhua Wang; Jinhua Zhang
Journal:  Cell Mol Neurobiol       Date:  2022-03-28       Impact factor: 5.046

5.  Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats.

Authors:  György Rumi; Ryouichi Tsubouchi; Mitsuaki Okayama; Shinichi Kato; Gyula Mózsik; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

Review 6.  Recent advances on prebiotic lactulose production.

Authors:  Azis Boing Sitanggang; Anja Drews; Matthias Kraume
Journal:  World J Microbiol Biotechnol       Date:  2016-07-27       Impact factor: 3.312

7.  Lactulose mediates suppression of dextran sodium sulfate-induced colon inflammation by increasing hydrogen production.

Authors:  Xiao Chen; Xiao Zhai; Jiazi Shi; Wen Wu Liu; Hengyi Tao; Xuejun Sun; Zhimin Kang
Journal:  Dig Dis Sci       Date:  2013-01-31       Impact factor: 3.199

8.  Double-blind prospective randomized study comparing polyethylene glycol to lactulose for bowel preparation in colonoscopy.

Authors:  Aline Moraes Menacho; Adriano Reimann; Lie Mara Hirata; Caroline Ganzerella; Flavio Heuta Ivano; Ricardo Sugisawa
Journal:  Arq Bras Cir Dig       Date:  2014 Jan-Mar

9.  Antifibrotic Effect of Lactulose on a Methotrexate-Induced Liver Injury Model.

Authors:  Banu Taskin; Mümin Alper Erdoğan; Gürkan Yiğittürk; Damla Günenç; Oytun Erbaş
Journal:  Gastroenterol Res Pract       Date:  2017-08-17       Impact factor: 2.260

Review 10.  Synthesis of novel bioactive lactose-derived oligosaccharides by microbial glycoside hydrolases.

Authors:  Marina Díez-Municio; Miguel Herrero; Agustín Olano; F Javier Moreno
Journal:  Microb Biotechnol       Date:  2014-04-01       Impact factor: 5.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.